NCT06877650 2026-01-29
First-in-Human Investigation of JMT108 Injection in Participants With Advanced Malignant Tumors
Shanghai JMT-Bio Inc.
Phase 1/2 Recruiting
Shanghai JMT-Bio Inc.
SUNHO(China)BioPharmaceutical CO., Ltd.
SUNHO(China)BioPharmaceutical CO., Ltd.